Monon Bioventures

Monon Bioventures is a biotechnology venture studio based in Indianapolis, Indiana, that focuses on translating high-potential academic research into commercial drug candidates. The company partners with leading research institutions, including Purdue University and Indiana University, to identify and de-risk early-stage therapeutic assets. Monon provides the necessary capital, management expertise, and operational support to advance these programs through pre-clinical development and toward the clinic. Their diverse pipeline includes small molecule inhibitors for oncology indications like pancreatic cancer and glioblastoma, as well as gene therapies for rare conditions such as genetic hearing loss. By utilizing a lean, virtual business model, Monon Bioventures aims to efficiently bridge the "valley of death" in drug discovery.